Identification of Immunodominant CD4-Restricted Epitopes Co-Located with Antibody Binding Sites in Individuals Vaccinated with ALVAC-HIV and AIDSVAX B/E-Reference-Cited by-同舟云学术

Identification of Immunodominant CD4-Restricted Epitopes Co-Located with Antibody Binding Sites in Individuals Vaccinated with ALVAC-HIV and AIDSVAX B/E

Published:2015-02-09 Issue:2 Volume:10 Page:e0115582
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ratto-Kim Silvia,de Souza Mark S.,Currier Jeffrey R.,Karasavvas Nicos,Sidney John,Rolland Morgane,Valencia-Micolta Anais,Madnote Sirinan,Sette Alessandro,Nitayaphan Sorachai,Pitisuttuthum Punnee,Kaewkungwal Jaranit,Rerks-Ngarm Supachai,O’Connell Robert,Michael Nelson,Robb Merlin L.,Marovich Mary,Kim Jerome H.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference16 articles.

1. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand;S Rerks-Ngarm;The New England journal of medicine,2009

2. Immune-correlates analysis of an HIV-1 vaccine efficacy trial;BF Haynes;The New England journal of medicine,2012

3. Induction of immunity to human immunodeficiency virus type-1 by vaccination;MJ McElrath;Immunity,2010

4. A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative thais.AFRIMS-RIHES Vaccine Evaluation Group. Armed Forces Research Institute of Medical Sciences and the Research Institute for Health Sciences;S Nitayaphan;Vaccine,2000

5. Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults;S Nitayaphan;The Journal of infectious diseases,2004

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytotoxic CD4+ T cells in chronic viral infections and cancer;Frontiers in Immunology;2023-10-25

2. Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults;Journal of Clinical Investigation;2023-02-15

3. Immunogenicity of Immunotoxins Containing Pseudomonas Exotoxin A: Causes, Consequences, and Mitigation;Frontiers in Immunology;2020-06-26

4. HIV Vaccine Efficacy Trials: RV144 and Beyond;HIV Vaccines and Cure;2018

5. Addressing the Immunogenicity of the Cargo and of the Targeting Antibodies with a Focus on Deimmunized Bacterial Toxins and on Antibody-Targeted Human Effector Proteins;Biomedicines;2017-06-02